[Treatment of S. typhi and S. paratyphi B carriers].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002353:Carrier State / Q000150:complications / Q000188:drug therapy*; D002642:Chick Embryo; D002763:Cholecystectomy; D002769:Cholelithiasis / Q000150:complications / Q000601:surgery; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010403:Penicillin Resistance; D012008:Recurrence; D012480:Salmonella Infections / Q000188:drug therapy*; D012482:Salmonella paratyphi A / Q000187:drug effects; D012485:Salmonella typhi / Q000187:drug effects; D013307:Streptomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D007612:Kanamycin; D000667:Ampicillin; D013307:Streptomycin
Zur Sanierung von Typhus- und Paratyphus-B-Dauerausscheidern.